Status:
ACTIVE_NOT_RECRUITING
Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Leiomyomas
Eligibility:
FEMALE
Phase:
NA
Brief Summary
It is known that volumetric response of leiomyomas following uterine artery embolization correlates well with patients clinical outcome. The aim of this study is to assess diffusion -and perfusion wei...
Eligibility Criteria
Inclusion
- women with symptomatic leiomyomas
Exclusion
- women with known contra-indications for MRI (cardiac pacemaker, cochlear implants, claustrophobic patients)
- women with contra-indications to gadolinium-based contrast agents (including patients with a known restricted renal function; GFR \< 30 mL/min)
Key Trial Info
Start Date :
January 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01514617
Start Date
January 1 2012
End Date
December 1 2025
Last Update
July 10 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radiology Department
Leuven, Belgium, 3000